| Role |
Name |
Disclosure |
Details |
| Author | Jacqueline Dolev, MD, Clinical Fellow, Department of Dermatology, University of California, San Francisco Medical Center | Nothing to disclose | Details | | Coauthor | Maryanne Kazanis, BA, Doris Duke Clinical Research Fellow, Clinical Unit for Research Trials in Skin, Department of Dermatology, Brigham and Women's Hospital | Nothing to disclose | Details | | Coauthor | Alexa F Boer Kimball, MD, MPH, Associate Professor of Dermatology, Harvard University School of Medicine; Vice Chair, Department of Dermatology, Massachusetts General Hospital; Director of Clinical Unit for Research Trials in Skin (CURTIS), Department of Dermatology, Massachusetts General Hospital and Brigham and Women's Hospital | Nothing to disclose | Details | | Medical Editor | Jacek C Szepietowski, MD, PhD, Professor, Vice-Head, Department of Dermatology, Venereology and Allergology, Wroclaw Medical University; Director of the Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Poland | Stiefel | Details | | Pharmacy Editor | David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Director, Dermatology Residency Training Program, Scott and White Clinic | 3M Pharmaceutical Graceway Pharmaceuticals | Details | | Managing Editor | Drore Eisen, MD, DDS, Consulting Staff, Department of Dermatology, Dermatology Research Associates of Cincinnati | Nothing to disclose | Details | | CME Editor | Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University | Nothing to disclose | Details | | Chief Editor | Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center | Nothing to disclose | Details |
|